Mettl3‐Mediated m6A Modification Represents a Novel Therapeutic Target for FSGS.

Saved in:
Bibliographic Details
Title: Mettl3‐Mediated m6A Modification Represents a Novel Therapeutic Target for FSGS.
Authors: Zhu, Fubin1, Li, Hongzhi1, Li, Xiang1, Du, Chunxiu2, Wang, Ting1, Zhou, Xuling1, Xie, Xiaobei1, Shao, Yunxia3, Huang, Yingzhi2, Hu, Yanling1, Guo, Xinxin1, Zhu, Bin4, Yu, Shanshan1, Zhang, Xiaoyan2, xyzhang@hsc.ecnu.edu.cn, Zhao, Binghai1,4, zhaobinghai01@beihua.edu.cn
Source: Advanced Science; 2/18/2026, Vol. 13 Issue 10, p1-15, 15p
Database: Applied Science & Technology Source
Full text is not displayed to guests.
Description
ISSN:21983844
DOI:10.1002/advs.202501242